Advanced Micro Devices (AMD) Is Up 15.2% After Data Center Beat And AI Edge Partnership News – What's Changed

Advanced Micro Devices, Inc.

Advanced Micro Devices, Inc.

AMD

0.00

  • In early May 2026, Advanced Micro Devices reported first‑quarter 2026 results showing revenue of US$10.25 billion and net income of US$1.38 billion, alongside guidance for second‑quarter revenue of about US$11.20 billion, plus or minus US$300 million, largely driven by strong demand for AI and data center chips.
  • Separately, Green Hills Software announced a collaboration with AMD to pair its safety‑certified real‑time operating systems and development tools with AMD’s Versal AI Edge Series Gen 2 SoCs, aiming to support complex, safety‑critical automotive, aerospace and robotics applications on a single hardware‑software stack.
  • We’ll now examine how AMD’s data center‑led growth surprise and stronger near‑term guidance may reshape its pre‑existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Advanced Micro Devices Investment Narrative Recap

To own AMD today, you have to believe its data center and AI franchises can justify a premium valuation while it manages acute competition, supply constraints and regulatory uncertainty. The Q1 2026 beat and Q2 guidance reinforce the near term AI and server CPU ramp as the key catalyst, while high expectations and execution risk around capacity, export controls and hyperscaler demand remain the biggest watch points.

Among recent announcements, I focus on AMD’s collaboration with Green Hills Software around the Versal AI Edge Series Gen 2 SoCs. While small next to headline data center wins, this deal underlines AMD’s push into safety critical automotive, aerospace and robotics workloads, which could add a steadier embedded and edge AI stream alongside the more cyclical, hyperscaler driven accelerator business that is currently in the spotlight.

Yet beneath the strong AI story, investors still need to be aware of how export controls and high manufacturing dependence could...

Advanced Micro Devices' narrative projects $86.1 billion revenue and $20.2 billion earnings by 2029. This requires 35.4% yearly revenue growth and about a $15.9 billion earnings increase from $4.3 billion today.

Uncover how Advanced Micro Devices' forecasts yield a $289.61 fair value, a 29% downside to its current price.

Exploring Other Perspectives

AMD 1-Year Stock Price Chart
AMD 1-Year Stock Price Chart

Some of the lowest analysts were already cautious, assuming revenue growth of about 33 percent a year and earnings of roughly US$14.4 billion by 2029, so this AI driven quarter may either ease their concerns about export and foundry risks or reinforce them, and you should recognize that informed opinions on AMD’s future can differ widely.

Explore 52 other fair value estimates on Advanced Micro Devices - why the stock might be worth as much as 10% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Advanced Micro Devices research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Advanced Micro Devices research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Advanced Micro Devices' overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • Rare earth metals are the new gold rush. Find out which 33 stocks are leading the charge.
  • AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.